Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies
Australian-based Oventus has received clearance from the U.S. Food and Drug Administration for an oral device to treat obstructive sleep apnea, according to a Sept. 2, 2019, company statement. The O2Vent Optima is a customized, 3D-printed, nylon oral device that stabilizes the patient’s upper [...]
Hoping to improve the nation’s sleep and expand its services to consumers, Walgreens has added sleep disorders to the growing list of chronic conditions it can help treat. The pharmacy’s digital platform, Find Care, connects consumers to health services like virtual doctor visits, online [...]
Today the U.S. Food and Drug Administration released a safety communication and consumer update to inform patients and health care providers about concerns related to CPAP cleaning devices that use ozone or ultraviolet light. CPAP is a common treatment for obstructive sleep apnea. [...]
Smartwatches just aren’t counting steps, they’re also trying to track your sleep. Fitbit, a leading wearable device company, now includes a sleep tracking feature in its Versa 2 smartwatch. It uses sensors, algorithms and intuitive technologies to evaluate the quality of a user’s sleep. [...]
The U.S. Food and Drug Administration has issued clearance to Resonea for an in-home sleep apnea screening device, according to a July 25, 2019, statement issued by the company. Drowzle is a prescription smartphone-based device that tracks symptoms and records breathing patterns during sleep [...]
An Israeli-based company has received clearance from the U.S. Food and Drug Administration for a new home sleep apnea test, according to a June 6, 2019, announcement from Itamar Medical. The company reports that its WatchPAT One is the first fully disposable home sleep [...]
Harmony Biosciences announced Aug. 15, 2019, that the U.S. Food and Drug Administration has approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. Harmony states that Wakix is the only treatment approved for patients with narcolepsy that is not [...]
Merck announced Feb. 3, 2020, that the U.S. Food and Drug Administration has updated the prescribing information for Belsomra (suvorexant) to include details about an insomnia study in patients with mild to moderate Alzheimer’s disease. Belsomra was first FDA-approved for the treatment of insomnia [...]
Since acquiring Aetna in 2018, CVS Health has set its sights on expanding its services in the health care market. The combined companies are taking steps to give consumers more control of their care while hoping to make it less expensive and easier to [...]
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced that the U.S. Food and Drug Administration has approved Dayvigo (lemborexant) 5 mg and 10 mg for the treatment of adult patients with sleep-onset insomnia and sleep maintenance insomnia. According to Eisai, the [...]